by TrN2016_SandWich | Apr 12, 2016 |
Philip Hedge Philip Hedge (PhD) is a bioscientist with 24 years of experience of cancer drug discovery at AstraZeneca. Philip has conducted and led research across all phases of research, including new target discovery, lead generation,...
by TrN2016_SandWich | Apr 12, 2016 |
Miri Seiberg Miri Seiberg is a life sciences R&D expert with a track record of research innovation. She has initiated and managed research and development programs in the fields of skin and mucosal tissue biology, resulting in novel drug candidates and successful...
by TrN2016_SandWich | Apr 12, 2016 |
Pirthipal Singh Pirthipal joined ICI in Dec 1978 (Natural Products Group) as an Experimental Officer, after graduating in Biochemistry from University of Leeds. He developed a range of radioligand binding assays and subsequently established the concept of high...
by TrN2016_SandWich | Apr 12, 2016 |
Dermott O’Callaghan Dermott O’Callaghan has over 9 years experience in the pharmaceutical industry. His focus has been on early drug discovery in neuroscience with an emphasis on ion channels. He has in-depth experience of numerous drug discovery approaches and...
by TrN2016_SandWich | Apr 12, 2016 |
Brendan Leighton Brendan Leighton, Ph.D., is a Biochemist who has provided professional bioscience services to the pharmaceutical industry since 1998. With more than 14 years of pharmaceutical industry experience, Dr. Leighton provides drug discovery...
